The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT03816657 · UNKNOWN

Trial details

NCT number: NCT03816657
Sponsor: Fondazione Ricerca Traslazionale
Status: UNKNOWN
Study type: OBSERVATIONAL

To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods

Start date: 2015-02-15
Primary completion: 2017-05-15
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.